ang. fedttab, "idealvægt" m.m.


laush
 Share

Recommended Posts

Bogen kan købes her: (det er en e-book)

http://www.qfac.com/qfacmain.html

I øvrigt tror jeg at at svaret på at holde ens set-point nede dvs. at holde fedtprocenten lav kan hjælpes på vej ved at spise sundt og sørge for at få de rigtige vitaminer, mineraler, fedtsyrer m.m., men det kræver også meget tid i en travl hverdag.

I øvrigt er her et "abstract" fra en undersøgelse om bromocriptine

Mvh Lau Saugman Hansen

Bromocriptine (Ergoset) reduces body weight and improves glucose tolerance

in obese subjects.

Cincotta AH, Meier AH.

Ergo Science, Charlestown, Massachusetts 02129, USA.

OBJECTIVE: A double-blind placebo controlled study investigated long-term

effects of Ergoset, a new quick release formulation of bromocriptine, on

body weight, body fat, and glucose tolerance in a group (n = 17) of obese

subjects who were instructed to follow a moderate hypocaloric diet. RESEARCH

DESIGN AND METHODS: Obese individuals (> 25% body fat for men and > 30% body

fat for women) were instructed to follow a calorie-restricted diet (70% of

weight maintaining based on study entry weight) and were randomized to daily

treatment with Ergoset (1.6-2.4 mg/day) or placebo at 0800 over an 18-week

treatment period. Oral glucose tolerance tests were performed on subjects

before initiation and again at termination of treatment. Body weight and

body fat (determined by skinfold measurements) were quantified every 2 weeks

during the course of treatment. RESULTS: Ergoset treatment for 18 weeks

significantly reduced body weight and body fat versus placebo (6.3 +/- 1.5

and 5.4 +/- 1.1 kg vs. 0.9 +/- 1.0 and 1.5 +/- 0.6 kg. respectively, P <

0.01). Ergoset, but not placebo, also improved glucose tolerance (P < 0.02);

the stimulated area under the oral glucose tolerance curve was reduced by

46% (from 121 +/- 23 to 64 +/- 32 mg.h-1.dl-1), while the stimulated area

under the insulin curve was reduced by 30%. CONCLUSIONS: When combined with

instruction to follow a moderate hypocaloric diet, Ergoset, but not placebo,

improves glucose tolerance and promotes significant weight and body fat loss

in obese subjects over an 18- week treatment period.

Link to comment
Share on other sites

nå, ja der var jeg lidt for langsom - fik ellers en mail fra Lyle McD.

Mette,

Actually, the 'article' was the first chapter of the bromocriptine booklet

in question, excerpted in whole. I guess Bryan didn't describe it as such

in the newsletter. Basically, it was simply the lead in to the rest of the

booklet (where explanations of how the body knows what's going on during

dieting, to how bromocriptine is one specific fix). The booklet can be

purchased in its entirety from http://www.qfac.com

Sincerely,

Lyle McDonald

Rart, når folk kan svare hurtigt ude i den store verden...

mvh mette

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

 Share